Viatris Korea celebrated 25 years of Lpitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at a press conference in Seoul on Wednesday.After its launch in 1997, Lipitor became the top-prescribed statin in Korea by 2
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial bladder cancer.Founded in 2016, Curigin has pioneered the development of siRNA technologies capable of suppressing multip
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partnership is set to advance the clinical research of Hanmi's dual-antibody therapy, BH3120, combined with MSD's immunothera
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara.Stelara, originally developed by Janssen, is used for treating plaque psoriasis, psoriatic arthritis, Crohn
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the Science of Botanicals, held in Oxford, Miss., from April 15 to 18.The International Conference on the Science of Botanica
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A (MPS IIIA), jointly developed with Korean biote
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions jointly.Kakao Healthcare CEO Hwang Hee and OURHOME CEO Koo Ji-eun signed the memorandum of understanding at Kakao Healt
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced Biomedicine Expedited Approval System.The system is designed to facilitate the rapid market entry of innovative medicine
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices among its employees. Plogging refers to picking up rubbish while jogging or walkingThis year marks the third installment
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximately 1.95 trillion won ($1.4 billion), Seoul Economic Daily said on Monday. This deal marks the largest transaction of it
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most common type of cancer among men globally, following lung cancer.Early detection significantly increases treatment options
Bridge Biotherapeutics, a Korean biotech firm, announced positive feedback from the third Independent Data Monitoring Committee (IDMC) meeting to continue the phase 2 clinical trial of BBT-877, a drug candidate for the treatment of idiopathic pulmonary fibrosis (IPF).IPF is a severe and chronic lung
The Ministry of Food and Drug Safety has granted approval to two more digital therapeutic (DTx) devices, developed by Nunaps and Share&Service. These devices, which are the third and fourth authorized DTx in the country, utilize software to assist in cognitive improvement and respiratory rehabilitat
3Bigs, a Korean company specializing in bio big data-based health management solutions, said it entered a distribution partnership with Neo-Science, a bio-health enterprise located in Abu Dhabi, the UAE.Under the accord, Neo-Science will manage the sales of several key 3Bigs products, including the
HLB said it opened a new office in the Cambridge Innovation Center (CIC) in Boston, U.S. to bolster the collaboration and communication between HLB and its U.S. subsidiaries, such as Immunomic Therapeutics, while also supporting its group companies' entry into international markets.HLB's new office
Handok and Swedish Orphan Biovitrum (Sobi) said they have officially inaugurated their Korean joint venture, Handok-Sobi.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments in hematology, immunology, and specialized therapies. With 1,800 employee
GC Cell said its U.S. affiliate Artiva Biotherapeutics has begun administering the first dose to a participant in a phase 1 clinical trial. This trial investigates the combination of AlloNK (AB-101) and rituximab as a potential treatment for lupus nephritis.Lupus nephritis is a complication of syste
Celltrion announced its decision to further buy back and retire its own shares as part of its ongoing efforts to stabilize its stock price and enhance shareholder value.The company stated that it would purchase approximately 436,047 shares for a total acquisition cost of about 75 billion won ($54.1
BNC Korea said it secured exclusive distribution rights in five Asian countries for Danish biotech firm Kariya's KP405 and KP404, both Alzheimer's and Parkinson's drug candidates that can cross the blood-brain barrier.The agreement, which encompasses Korea, Singapore, Thailand, Indonesia, and Malays
A research team at Korea University Guro Hospital (KUGH) and Harvard Medical School has developed the "world’s first" dual fluorescence imaging technique for precision lung cancer surgery.Recent developments in lung cancer surgery aim to completely remove cancer tissues while preserving as much heal